Jant Pharmacal Corporation is Awarded Contract from Vizient.
Encino, CA – January 7, 2020 – Jant Pharmacal Corporation announces it has been awarded a contract with Vizient, Inc. for its complete line of rapid test kits. The contract takes effect February 1, 2020, and offers enhanced savings on the test kits for Vizient members.
The contract covers Jant’s full line of test kits, which is comprised of tests for cancer screening, drugs of abuse, infectious disease, pregnancy, and urinalysis.
Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and nonacute health care providers and represents more than $100 billion in annual purchasing volume.
About Jant Pharmacal Corporation
Jant Pharmacal is a major supplier of medical testing devices for use in physician’s offices, clinics, hospitals and laboratory practice settings. Point of care products are marketed under registered trademarks Accutest® and Accustrip®. Established in 1986, Jant Pharmacal’s point of care diagnostic products are FDA cleared, CLIA-waived and are backed by over 30 years of experience and industry leadership.
In addition, Jant Pharmacal offers a comprehensive line of laboratory equipment, including clinical chemistry, hematology, immunoassay, molecular and urinalysis systems and reagents, as well as consultative services, to enhance laboratory efficiency and profitability.
More information on the Company’s products and services can be found on their website, www.JantDx.com. Their customer service team can be reached by email at info@JantDX.com or by phone at (800) 676-5565.